InvestorsHub Logo
Followers 9
Posts 309
Boards Moderated 0
Alias Born 06/23/2011

Re: reg2015 post# 246918

Thursday, 10/10/2019 4:19:17 PM

Thursday, October 10, 2019 4:19:17 PM

Post# of 698380
In the company's description of itself, it states that it is:

a clinical-stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins.


So the answer to your question is "No, it is not DCVax technology".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News